| Harout Semerjian | President and Chief Executive Officer (as of August 7, 2025) | FY2025 | |
| John A. Scarlett, M.D. | Former Chairman of the Board, President and Chief Executive Officer | FY2025 | |
| Andrew J. Grethlein, Ph.D. | Former Executive Vice President, Chief Operating Officer | FY2025 | |
| Ahmed ElNawawi | Executive Vice President, Chief Commercial Officer (as of October 20, 2025) | FY2025 | |
| James Ziegler | Former Executive Vice President, Chief Commercial Officer (as of September 9, 2024) | FY2025 | |
| Michelle Robertson | Executive Vice President, Finance, Chief Financial Officer, Treasurer and Interim Secretary | FY2025 | |
| Joseph Eid, M.D. | Executive Vice President, Research & Development, Chief Medical Officer (as of November 11, 2024) | FY2025 | |
| Dawn Carter Bir | Former Interim President and Chief Executive Officer (as of March 17, 2025) | FY2025 |
8 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.